Revolution Medicines Inc (RVMD) — Cash Flow-to-Debt Ratio
Revolution Medicines Inc (RVMD) has a Cash Flow-to-Debt Ratio of -0.32x as of September 2025, meaning its operating cash flow of $-207.31 Million could theoretically repay 0% of its total liabilities ($655.02 Million) in one year. See Revolution Medicines Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Revolution Medicines Inc Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Revolution Medicines Inc across 8 annual periods. Also explore Revolution Medicines Inc (RVMD) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Revolution Medicines Inc (2017–2024)
Year-by-year debt coverage analysis for Revolution Medicines Inc. For market capitalisation and broader financial context, see RVMD stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.90x | $-557.44 Million | $293.10 Million | ▼ -27.8% |
| 2023 | -1.49x | $-350.57 Million | $235.51 Million | ▲ +15.9% |
| 2022 | -1.77x | $-224.40 Million | $126.74 Million | ▼ -62.9% |
| 2021 | -1.09x | $-147.18 Million | $135.42 Million | ▼ -0.7% |
| 2020 | -1.08x | $-100.06 Million | $92.72 Million | ▼ -47.9% |
| 2019 | -0.73x | $-49.62 Million | $67.99 Million | ▼ -4547.3% |
| 2018 | 0.02x | $1.21 Million | $73.93 Million | ▲ +100.7% |
| 2017 | -2.38x | $-25.15 Million | $10.55 Million | — |